Dyne Therapeutics Inc (DYN)
23.99
-0.31
(-1.28%)
USD |
NASDAQ |
Dec 20, 16:00
25.18
+1.19
(+4.96%)
After-Hours: 20:00
Dyne Therapeutics Enterprise Value: 1.718B for Dec. 20, 2024
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Vertex Pharmaceuticals Inc | 95.78B |
| Regenxbio Inc | 122.57M |
| Avidity Biosciences Inc | 2.208B |
| Catalyst Pharmaceuticals Inc | 2.095B |
| Sarepta Therapeutics Inc | 11.39B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -97.12M |
| Total Expenses (Quarterly) | 105.66M |
| EPS Diluted (Quarterly) | -0.96 |
| Earnings Yield | -14.84% |